Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa

IF 2.5 Q3 ENDOCRINOLOGY & METABOLISM
Kazuki Fujimoto , Narumi Maki , Daisuke Hashiba , Toshifumi Maeyama , Ryosuke Nakagawa , Hajime Arai , Seiji Ohtori
{"title":"Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa","authors":"Kazuki Fujimoto ,&nbsp;Narumi Maki ,&nbsp;Daisuke Hashiba ,&nbsp;Toshifumi Maeyama ,&nbsp;Ryosuke Nakagawa ,&nbsp;Hajime Arai ,&nbsp;Seiji Ohtori","doi":"10.1016/j.afos.2023.10.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.</div></div><div><h3>Methods</h3><div>In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.</div></div><div><h3>Results</h3><div>BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.</div></div><div><h3>Conclusions</h3><div>Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.</div></div>","PeriodicalId":19701,"journal":{"name":"Osteoporosis and Sarcopenia","volume":"9 4","pages":"Pages 137-141"},"PeriodicalIF":2.5000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Osteoporosis and Sarcopenia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405525523000687","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.

Methods

In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.

Results

BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.

Conclusions

Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.
罗莫单抗对患有严重骨质疏松症和神经性厌食症的绝经前妇女的影响
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Osteoporosis and Sarcopenia
Osteoporosis and Sarcopenia Orthopedics, Sports Medicine and Rehabilitation, Endocrinology, Diabetes and Metabolism, Obstetrics, Gynecology and Women's Health, Geriatrics and Gerontology
自引率
5.00%
发文量
23
审稿时长
66 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信